BALA CYNWYD, Pa., March 8, 2012 /PRNewswire/ -- Law office of
Brodsky & Smith, LLC announces that it is investigating Chemed
Corporation ("Chemed" or the "Company") (NYSE: CHE) investment of
Plan participants and beneficiaries assets in company stock. The
investigation concerns whether administrators breached their
fiduciary duties and violated the Employee Retirement Income
Security Act of 1974 ("ERISA") by investing and/or continuing to
invest assets in company stock when it was not a prudent investment
for participants' retirement savings.
The investigation concerns improper behavior that harmed current
and former employees that invested in the 401(k) plan.
Specifically, a class action lawsuit has been filed that alleges
that the Company issued materially false and misleading statements
concerning the Company's business and prospects. It is alleged that
the defendants failed to disclose that Chemed engaged in a scheme
to fraudulently bill Medicare for hospice services and failed to
maintain adequate controls in its hospice enrollments and Medicare
billings. It has been reported that a whistleblower complaint has
also been filed alleging similar misconduct.
If you held Chemed stock in the Chemed/Roto-Rooter Savings &
Retirement Plan and wish to discuss the legal ramifications of the
administrator's investment in Company stock, you may e-mail or call
the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions.
You may contact Jason L. Brodsky,
Esquire or Evan J. Smith,
Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
602, Bala Cynwyd, PA 19004, by
e-mail at investorrelations@brodsky-smith.com, visiting
http://brodsky-smith.com/393-che-chemed-corporation.html, or by
calling toll free 877-LEGAL-90.
SOURCE Brodsky & Smith, LLC